liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways
The University of Hong Kong, Hong Kong.
The University of Hong Kong, Hong Kong.
Linköping University, Department of Clinical and Experimental Medicine, Division of Cell Biology. Linköping University, Faculty of Medicine and Health Sciences.
The University of Hong Kong, Hong Kong.
2015 (English)In: OncoTarget, ISSN 1949-2553, E-ISSN 1949-2553, Vol. 6, no 42, 44422-44436 p.Article in journal (Refereed) Published
Abstract [en]

We hypothesize that miR-3151, localized to a GWAS-identified chronic lymphocytic leukemia (CLL) risk locus (8q22.3), is a tumor suppressor miRNA silenced by promoter DNA methylation in CLL. The promoter of miR-3151 was methylated in 5/7 (71%) CLL cell lines, 30/98 (31%) diagnostic primary samples, but not normal controls. Methylation of miR-3151 correlated inversely with expression. Treatment with 5-Aza-2'-deoxycytidine led to promoter demethylation and miR-3151 re-expression. Luciferase assay confirmed MAP-kinase activating death domain (MADD) and phosphoinositide-3-kinase, regulatory subunit 2 (PIK3R2) as direct targets of miR-3151. Moreover, restoration of miR-3151 resulted in inhibition of cellular proliferation and enhanced apoptosis, repression of MADD and PIK3R2, downregulation of MEK/ERK and PI3K/AKT signaling, and repression of MCL1. Lastly, miR-3151 methylation was significantly associated with methylation of miR-203 and miR-34b/c in primary CLL samples. Therefore, this study showed that miR-3151 is a tumor suppressive miRNA frequently hypermethylated and hence silenced in CLL. miR-3151 silencing by DNA methylation protected CLL cells from apoptosis through over-expression of its direct targets MADD and PIK3R2, hence constitutive activation of MEK/ERK and PI3K/AKT signaling respectively, and consequently over-expression of MCL1.

Place, publisher, year, edition, pages
2015. Vol. 6, no 42, 44422-44436 p.
Keyword [en]
DNA methylation; chronic lymphocytic leukemia; miR-3151; microRNA; tumor suppressor
National Category
Cell and Molecular Biology
URN: urn:nbn:se:liu:diva-122624DOI: 10.18632/oncotarget.6251PubMedID: 26517243OAI: diva2:869029
Available from: 2015-11-12 Created: 2015-11-12 Last updated: 2016-04-07

Open Access in DiVA

fulltext(1218 kB)60 downloads
File information
File name FULLTEXT01.pdfFile size 1218 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Rosén, Anders
By organisation
Division of Cell BiologyFaculty of Medicine and Health Sciences
In the same journal
Cell and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 60 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 163 hits
ReferencesLink to record
Permanent link

Direct link